시장보고서
상품코드
1270703

세계의 전신 마취제 시장 규모, 점유율, 성장 분석 : 약제 유형별, 투여 경로별, 수술 유형별, 최종사용자별 - 업계 예측(2022-2028년)

Global General Anesthesia Drugs Market Size, Share, Growth Analysis, By Type of Drug, By Route of Administration, By Surgery Type, By End-User - Industry Forecast 2022-2028

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 전신 마취제 시장 규모는 2022년 55억 9,000만 달러에서 2030년까지 77억 달러에 달하며, 예측 기간(2023-2030년)에 CAGR로 3.5%의 성장이 예측됩니다. 시장은 수술 건수의 증가, 만성질환의 유행, 약물전달 시스템에서 기술의 진보 등의 요인에 의해 촉진되고 있습니다.

세계의 전신 마취제 시장에 대해 조사분석했으며, 시장 역학과 전망, 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

주요 요약

시장의 개요

모시장 분석

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장의 에코시스템
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표

COVID-19의 영향

  • 서론
  • 경제에 대한 영향 - 시나리오 평가
  • 시장 규모 수정
  • 주요 부문에 대한 COVID-19의 영향
  • COVID-19 전략 : 기업별

시장 역학과 전망

  • 시장 역학
  • 촉진요인
  • 기회
  • 억제요인
  • 과제
  • 규제 상황
  • SWOT 분석
  • Porter의 산업 분석
  • 향후 혼란에 관한 특별한 인사이트

세계의 전신 마취제 시장 : 약제 유형별

  • 시장 부문
  • 프로포폴
  • 세보플루란
  • Desflurane
  • 기타

세계의 전신 마취제 시장 : 투여 경로별

  • 시장 부문
  • 정맥주사
  • 흡입

세계의 전신 마취제 시장 : 수술 유형별

  • 시장 부문
  • 슬관절·고관절 치환술
  • 심장 수술
  • 암수술
  • 일반 수술

세계의 전신 마취제 시장 : 최종사용자별

  • 시장 부문
  • 병원
  • 외래 수술 센터

시장 규모 : 지역별

  • 북미
  • 미국
  • 캐나다
  • 유럽
  • 독일
  • 스페인
  • 프랑스
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 브라질
  • 기타 남미
  • 중동 및 아프리카
  • GCC 국가
  • 남아프리카공화국
  • 기타 중동 및 아프리카

주요 기업 개요

  • 경쟁 구도
  • 포함되는 기업의 총수
  • 주요 기업의 시장 포지셔닝
  • 주요 기업의 시장 점유율
KSA 23.05.19

Global General Anesthesia Drugs Market size was valued at USD 5.4 billion in 2021 and is poised to grow from USD 5.59 billion in 2022 to USD 7.7 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).

The global general anesthesia drugs market refers to the pharmaceuticals used to induce a state of unconsciousness or deep sedation in patients during medical procedures. These drugs work by blocking the nerve signals that transmit pain and other sensations to the brain. The market is driven by factors such as the increasing number of surgeries, growing prevalence of chronic diseases, and technological advancements in drug delivery systems. Major drug classes include inhalation anesthetics, intravenous anesthetics, and others.

Top-down and bottom-up approaches were used to estimate and validate the size of General Anesthesia Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global General Anesthesia Drugs market is segmented based on Type of Drug, Surgery Type, End-User, Route of Administration, and Region. Based on Type of Drug the market is segmented into Propofol, Sevoflurane, Desflurane, Others. Based on End-User the market is segmented into Hospital, Ambulatory surgical centres. Based on Surgery Type the market is segmented into Knee and hip replacements, Heart surgeries, Cancer surgery, General surgery. Based on Route of Administration the market us segmented into Intravenous, Inhalation. Based on region the global General Anesthesia Drugs market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

Over the past few decades, there has been a significant increase in the incidence of cancer in the United States. The National Cancer Institute has estimated that there are approximately 16.9 million cancer survivors in the country, a number that is projected to increase to 22.2 million by the year 2030. The most commonly diagnosed cancers include lung and bronchus cancer, breast cancer, prostate cancer, melanoma of the skin, colon and rectum cancer, bladder cancer, non-Hodgkin lymphoma, endometrial cancer, leukemia, kidney and renal pelvic cancer, pancreatic cancer, thyroid cancer, and liver cancer. Prostate, lung, and colorectal cancers are expected to account for 43% of all cancers diagnosed in men by 2020, whereas breast, lung, and colorectal cancer will account for more than half of all new malignancies diagnosed in women in 2020. As cancer surgery is often the most effective treatment for many tumors, especially when the cancer is localized, the increased prevalence of cancer will result in a rise in the number of surgical procedures performed. Given that general anesthesia is frequently used during cancer surgery, the US general anesthesia market is also expected to grow in line with the rising incidence of cancer.

Restraint

Extra caution is needed when using pharmacologic agents, especially general anaesthetic medicines, on paediatric patients. This is because infants and young children react differently to anaesthetic medicines compared to adults due to various factors, including body composition, protein binding, body temperature, cardiac output distribution, and the functional maturity of their liver and kidneys. Research studies have shown that administering general anaesthetics and sedative medicines to pregnant animals and young animals for more than three hours resulted in extensive nerve cell death in the brain. However, recent studies on humans indicate that a single, brief exposure to general anaesthetics and sedative medicines in new-borns or toddlers is unlikely to have a negative impact on their behavior or learning. Despite this, the US Food and Drug Administration has issued additional cautions on the use of general anaesthetics and sedative medicines in young children and pregnant women. Although general anaesthetics and sedative medicines are necessary for patients requiring surgery or other unpleasant and stressful treatments, including small children and pregnant women, repeated or prolonged use of these medications during operations or procedures in children under the age of three and pregnant women may pose potential harm. This possible danger has caused healthcare providers to be cautious in the adoption of general anaesthetics, which could impede market growth.

Trend

The growth of the general anaesthesia market is expected to be driven by the extensive focus of researchers on research and development of anaesthetic drugs during the forecast period. Recently, a team of researchers from the University of Michigan and the Washington University School of Medicine in St. Louis conducted experiments aimed at identifying the most effective anaesthetic medications for optimal clinical outcomes and patient recovery experiences. The study involved evaluating the effectiveness of popular anaesthetic drugs such as inhaled anaesthetics and intravenous propofol. This research highlights the ongoing efforts to improve anaesthesia delivery and patient outcomes through scientific research.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global General Anesthesia Drugs Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
  • Exhibit: Data Table on Global Global General Anesthesia Drugs Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
  • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Global General Anesthesia Drugs Market by Type of Drug
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Propofol
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Sevoflurane
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Desflurane
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global General Anesthesia Drugs Market by Route of Administration
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Intravenous
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Inhalation
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global General Anesthesia Drugs Market by Surgery Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Knee
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • hip replacements
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Heart surgeries
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Cancer surgery
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • General surgery
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global General Anesthesia Drugs Market by End-User
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Hospital
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Ambulatory Surgical Centres
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
  • Total number of companies covered
  • Exhibit: companies covered in the report, 2021
  • Top companies market positioning
  • Exhibit: company positioning matrix, 2021
  • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2021(%)
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제